Avanos Medical (AVNS) Finished Goods (2014 - 2026)

Avanos Medical has disclosed Finished Goods across 13 years of filings, most recently posting $78.2 million for Q1 2026.

• In Q1 2026, Finished Goods rose 4.55% year-over-year to $78.2 million; the TTM figure through Mar 2026 stood at $78.2 million (up 4.55% YoY), while the FY2025 annual figure was $84.0 million, up 7.28% from the prior year.
• Finished Goods came in at $78.2 million for Q1 2026 at Avanos Medical, down from $84.0 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $103.4 million in Q1 2023 to a low of $69.8 million in Q4 2022.
• Average Finished Goods over 5 years is $83.4 million, with a median of $84.0 million recorded in 2024.
• Year-over-year, Finished Goods advanced 29.57% in 2023 and declined 18.76% in 2024.
• Over 5 years, Finished Goods stood at $69.8 million in 2022, then advanced by 26.79% to $88.5 million in 2023, then decreased by 11.53% to $78.3 million in 2024, then climbed by 7.28% to $84.0 million in 2025, then decreased by 6.9% to $78.2 million in 2026.
• Per Business Quant data, the three most recent Finished Goods figures were $78.2 million in Q1 2026, $84.0 million in Q4 2025, and $80.2 million in Q3 2025.